External Innovation and Translation Intermediaries
External Innovation and Translation Intermediaries (EITIs) work to drive collaboration and knowledge transfer between researchers in our Innovation Districts and industry.
The goal of an EITI is to ensure South Australian innovations are translated to deliver new products, processes and services to domestic and international markets.
EITIs will complement and support internal intermediary functions which may already be present within the Innovation Districts, such as technology transfer offices.
The establishment of EITIs in major South Australian Innovation Districts is an initiative of EXCITE, the state’s 10-year science and innovation strategy.
Adelaide BioMed City – Expressions of interest invited
The South Australian Government is partnering with Adelaide BioMed City, a Health and Medical Innovation and Translation District, to engage an External Innovation and Translation Intermediary.
Up to $3 million is available over three years to support this activity.
This EITI will be tasked with growing the health and medical industry sector (e.g. health and med tech, biotech, pharma, clinical trials, digital health care) as a percentage of South Australia’s gross state product (GSP) and productivity.
They will also power up performance across the research, innovation and translation value chain to deliver better health outcomes for South Australia and beyond.
Applicants must meet the eligibility criteria as set out in the Guidelines. We encourage you to view the Guidelines and FAQs below, and email us with any enquiries
Frequently Asked Questions
The establishment of EITIs in major Innovation Districts is a key action from our EXCITE strategy, to address opportunities highlighted by the South Australian Productivity Commission R&D Inquiry Report (2021).
EITIs play key leadership roles in supporting a culture of collaboration, and work to leverage funding from a range of industry and government sources to secure infrastructure and amenities for their District. They can also build competitive differentiation in the national and global context to secure increased market access.
In South Australia, significant investment has been made by State and Federal governments, research institutions and industry into the establishment of Innovation Districts.In this context,the South Australian Government will partner with Innovation Districts to engage EITIs, committing $3 million over three years to two districts (the first of which is Adelaide BioMed City).
University technology transfer offices (TTOs) or technology licensing offices (TLOs) are responsible for technology transfer and other aspects of the commercialisation of research that takes place in a university.
EITIs act to complement and support internal intermediary functions, which may already be present in partner organisations within the Innovation Districts, to address any gaps in the innovation ecosystem.
The types of gaps can be categorised as follows:
- Information gaps—gaps encountered by firms in identifying relevant, useful and applicable techniques for product and service development.
- Access gaps—difficulties encountered by firms in accessing technologies and knowledge which they know to exist but are unsure about how to go about acquiring it.
- Transfer gaps—negotiation of licence and consultancy/contract agreements, as well as project management.
- Translation gaps—developing and transforming knowledge embedded in a technology into a form and format that can be used in product, service and/or business development.
Expressions of interest are open until 5pm Monday 9 August, with the successful applicant to be announced in late 2021.
The External Innovation and Translation Intermediaries program is an initiative of the Government of South Australia’s EXCITE strategy, delivered in partnership with Adelaide BioMed City.